Nektar(NKTR) - 2024 Q2 - Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Vivian Wu - Associate Director, Investor Relations & Corporate Affairs Howard Robin - President, Chief Executive Officer & Director Jonathan Zalevsky - Chief Research & Development Officer Mary Tagliaferri - Chief Medical Officer Sandra Gardiner - Chief Financial Officer Conference Call Participants Jay Olson - Oppenheimer Kambiz Yazdi - Jefferies Andy Hsieh - William Blair Arthur He - H.C. Wain ...